Sarvam Multi System Of Medicine And Research Institute Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 0.67%
- Profit Growth -12.02%
- Ebitda -61.68%
- Net Worth 4.10%
- Total Assets 2.67%
About Sarvam Multi System Of Medicine And Research Institute
Sarvam Multi System Of Medicine And Research Institute Private Limited (SMSOMARIPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 December 2015 (Nine years and two months 1 days old ). Its registered office is in Namakkal, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sri Sarvananda and Kuppanan Kannan serve as directors at the Company.
Company Details
-
Location
Namakkal, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74120TZ2015PTC022077
-
Company No.
022077
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Dec 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Sarvam Multi System Of Medicine And Research Institute?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sri Sarvananda
|
Director | 17-Dec-2015 | Current |
|
Kuppanan Kannan
|
Director | 17-Dec-2015 | Current |
Financial Performance of Sarvam Multi System Of Medicine And Research Institute.
Sarvam Multi System Of Medicine And Research Institute Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 0.67% increase. The company also saw a substantial fall in profitability, with a 12.02% decrease in profit. The company's net worth moved up by a moderate rise of 4.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sarvam Multi System Of Medicine And Research Institute?
In 2017, Sarvam Multi System Of Medicine And Research Institute had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sarvam Multi System Of Medicine And Research Institute?
Unlock and access historical data on people associated with Sarvam Multi System Of Medicine And Research Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sarvam Multi System Of Medicine And Research Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sarvam Multi System Of Medicine And Research Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.